Use of magnetic resonance spectroscopy for in vivo evaluation of high- energy phosphate metabolism in normal and abnormal myocardium

Journal of Cardiovascular Magnetic Resonance

Volumn 2, Issue 1, 2000, Pages 23-32

  Zhang, Jianyi ^a,b   Ugurbil, Kamil ^a,b   From, Arthur H L ^a,c   Bache, Robert J ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Deoxymyoglobin; High energy phosphates; Left ventricular hypertrophy; Left ventricular remodeling; Myocardial ischemia

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE METABOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGENATION; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SWINE;

EID: 0034082884     PISSN: 10976647     EISSN: None     Source Type: Journal    
DOI: 10.3109/10976640009148670     Document Type: Article

References (38)

1. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation, 1992; 86:1810-1818.
2. 31P NMR spectroscopy of the human heart at 4 Tesla: detection of substantially uncontaminated cardiac spectra and differentiation of subepicardium and subendocardium. Magn Reson Med, 1992; 26:368-376.
3. Bottomley PA. MR spectroscopy of the human heart: the status and the challenges. Radiology, 1994; 191:593-612.
4. 31P magnetic resonance spectroscopy of the Sherpa heart: a phosphocreatine/adenosine triphosphate signature of metabolic defense against hypobaric hypoxia. Proc Natl Acad Sci USA 1996; 93:1215-1220.
5. Neubauer S, Horn M, Godde M, Ertl G and Ingwall JS. The myocardial phosphocreatine/ATP ratio is a predictor of mortality in patents with dilated cardiomyopathy. Circulation, 1997; 96:2190-2196.
6. Balaban RS, Kantor HL, Katz LA and Briggs RW. Relation between work and phosphate metabolites in the in vivo paced mammalian heart. Science, 1986; 232:1121-1123.
7. Path G, Robitaille P-M, Merkle H, Tristani M, Zhang J, Garwood M, From AHL, Bache RJ and Ugurbil K. The correlation between transmural high energy phosphate levels and myocardial blood flow in the presence of graded coronary stenosis. Circ Res, 1990; 67;660-673.
8. Schaefer S, Schwartz GG, Wisneski JA, Trocha SD, Christoph I, Steinman SK, Garcia J, Massie BM and Weiner MW. Response of high-energy phosphates and lactate release during prolonged regional ischemia in vivo. Circulation, 1992; 85:342-349.
9. Zhang J, Path G, Ghepuri V, Xu Y, Yoshiyama M, Bache RJ, From AHL and Ugurbil K. Responses of myocardial high energy phosphates and wall thickening to prolonged regional hypoperfusion induced by subtotal coronary stenosis. Magn Reson Med, 1993; 30;28-37.
10. Zhang J, Merkle H, From AHL, Ugurbil K and Bache RJ. Bioenergetic abnormalities associated with severed left ventricular hypertrophy. J Clin Invest, 1993; 92:993-1003.
11. Massie BM, Schwartz GG, Garcia J, Wisneski JA, Weiner MW and Twyman O. Myocardial metabolism during increased work states in the porcine left ventricle in vivo. Circ Res, 1994; 74:64-73.
12. Bache RJ, Zhang J, Path G, From AHL, Bache RJ and Ugurbil K. Myocardial high energy phosphate levels during tachycardia and inotropic stimulation in the chronically pressure overloaded hypertrophied left ventricle. Am J Physiol, 1994; 266:H1959-H1970.
13. Massie BM, Schaefer S, Garcia J, McKirnan D, Schwartz GG, Wisneski JA, Weiner MW and White FC. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation, 1995; 91:1814-1823.
14. Zhang J, Path G, Chepuri V, Homans DC, Merkle H, Hendrich K, Ugurbil K, Bache RJ and From AHL. Effects of dobutamine on myocardial blood flow, contractile function, and bioenergetic responses distal to a coronary stenosis. Implications with regard to dobutamine stress testing. Am Heart J, 1995; 129:330-342.
15. Zhang J and McDonald K. Bioenergetic consequence of left ventricular remodeling secondary to discrete myocardial infarction. Circulation, 1995; 92:1011-1019.
16. 31P NMR study. Am J Physiol, 1995; 268:H1891-H1905.
17. 31P NMR spectroscopic study. Circulation, 1995; 92: 1274-1283.
18. 31P MRS study. Circulation, 1996; 94:1089-1099.
19. Zhang J, Toher C, Erhard M, Zhang Y, Ugurbil K, Bache RJ, Lange T and Homans DC. Bioenergetic and functional consequences of left ventricular volume overload hypertrophy. Circulation, 1997; 96:334-343.
20. Ingwall JS. Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles. Am J Physiol, 1982; 242:H729-H744.
21. 1H NMR spectroscopy study. Magn Reson Med, 1997; 38:193-197.
22. Neubauer S, Horn M, Naumann A, Tian R, Hu K, Laser M, Friedrich J, Gaudron P, Schnackerz K, Ingwall JS and Ertl G. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest, 1995; 95:1092-1100.
23. Zimmer GA, Zimmermann R, Hess OMS, Schneider J, Kubler W, Krayenbuehl HP, Hagl S and Mall G. Decreased concentration of myofibrils and myofiber hypertrophy are structural determinants of impaired left ventricular function in patients with chronic heart diseases: a multiple logistic regression analysis. J Am Coll Cardiol, 1992; 20:1135-1142.
24. Schwartz A, Sordahl LA, Entman ML, Allen JC, Reddy YS, Goldstein MA, Luchi RJ and Wyborny LE. Abnormal biochemistry in myocardial failure. Am J Cardiol, 1975; 32:407-422.
25. Alpen NR, Muleiri LA, Hasenfuss G and Holubarsch. Myocyte reorganization in hypertrophied and failing hearts. Eur Heart J, 1995; 16:2-7.
26. Harding SE, Jones M, Vescovo G, Del Monte F and Poole-Wilson PA. Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle. Eur J Pharmacol, 1992; 223: 39-48.
27. Pieske B, Kretschmann B, Meyer M, Holubarsch C, Weirich J, Posival H, Minami K, Just H and Hasenfuss G. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation, 1995; 92:1169-1178.
28. Hasenfuss G, Mulieri LA, Leavitt BJ, Allen PD, Holubarsch C, Just H and Alpert NR. Contractile protein function in failing and nonfailing human myocardium. Bas Res Cardiol, 1992; 87:106.
29. Hasenfuss G, Mulieri LA, Leavitt BJ, Allen PD, Haeberle JR and Alpert NR. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res, 1992; 70:1225-1232.
30. Ugurbil K and From AHI. Nuclear magnetic resonance studies of kinetics and regulation of oxidative ATP synthesis in the myocardium. In: Schafer S, Balaban RS, eds. Cardiovascular Magnetic Resonance Spectroscopy. New York: Kluwer Academic Publishers, 1992:63-92.
31. Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med, 1989; 322:100-110.
32. Murakami Y, Zhang Y, Cho YK, Mansoor AM, Chung JK, Chu C, Francis G, Ugurbil K, Bache RJ, From AHL, Jerosch-Herold M, Wilke N and Zhang J. Myocardial oxygenation during high work states in hearts with postinfarction remodeling. Circulation, 1999; 99:942-948.
33. Zimmer SD, Michurski SP, Mohanakrishnan P, Ulstad VK, Ugurbil K, Foker JE and From AHL. Alterations in oxidative function and respiratory regulation in the post-ischemic myocardium. J Biol Chem, 1989; 246:12402-12411.
34. From AHL, Zimmer SD, Michurski SP, Mohanakrishnan P, Ulstad VK, Thoma WJ and Ugurbil K. Regulation of the oxidative phosphorylation rate in the intact cell. Biochemistry, 1990; 29:3731-3743.
35. 1H-nuclear magnetic resonance deoxymyoglobin signal as indicator of intracellular oxygenation in myocardium. Am J Physiol, 1991; 261: H2091-H2097.
36. 1H nuclear magnetic resonance signal of myoglobin. Am J Physiol, 1995; 268:H1675-H1681.
37. Robitaille P-M, Merkle H, Sublett E, Hendrich K, Lew B, Path G, From AHL, Bache RJ and Ugurbil K. Spectroscopic imaging and spatial localization using adiabatic pulses and applications to detect transmural metabolite distribution in the canine heart. Magn Reson Med, 1989; 10:14-37.
38. Hendrich K, Merkle H, Weisdorf S, Vine W, Garwood M and Ugurbil K. Phase modulated rotating frame spectroscopic localization using an adiabatic plane rotation pulse and a single surface coil. J Magn Reson, 1991; 92: 258-275.